All Stories

  1. Cytotoxic and antifungal activities of melleolide antibiotics follow dissimilar structure–activity relationships
  2. Draft Genome Sequence of Streptomyces iranensis
  3. Fungal‐Actinomycete Interactions – Wakening of Silent Fungal Secondary Metabolism Gene Clusters via Interorganismic Interactions
  4. Bacterium Induces Cryptic Meroterpenoid Pathway in the Pathogenic Fungus Aspergillus fumigatus
  5. Differential expression of silent polyketide biosynthesis gene clusters in chemostat cultures of Aspergillus nidulans
  6. Regulatory Cross Talk and Microbial Induction of Fungal Secondary Metabolite Gene Clusters
  7. Cytotoxic Pheofungins from an Engineered Fungus Impaired in Posttranslational Protein Modification
  8. Cytotoxic Pheofungins from an Engineered Fungus Impaired in Posttranslational Protein Modification
  9. Bacteria-induced natural product formation in the fungus Aspergillus nidulans requires Saga/Ada-mediated histone acetylation
  10. Two Induced Fungal Polyketide Pathways Converge into Antiproliferative Spiroanthrones
  11. Fungal secondary metabolites – Strategies to activate silent gene clusters
  12. Comparative and functional genomics provide insights into the pathogenicity of dermatophytic fungi
  13. Activation of a Silent Fungal Polyketide Biosynthesis Pathway through Regulatory Cross Talk with a Cryptic Nonribosomal Peptide Synthetase Gene Cluster
  14. Intimate bacterial–fungal interaction triggers biosynthesis of archetypal polyketides in Aspergillus nidulans
  15. Fungal Genome Mining and Activation of Silent Gene Clusters
  16. Resuscitation-promoting factors: distribution among actinobacteria, synthesis during life-cycle and biological activity
  17. IN VITRO BIOSYNTHESIS OF AN AI-2 LIKE BACTERIAL AUTOINDUCER BY RECOMBINANT ESCHERICHIA COLI ENZYMES
  18. Expression of soluble, recombinant αvβ3 integrin fragments in Escherichia coli
  19. The use of elements of the E. coli Ntr-system for the design of an optimized recombinant expression system for high cell density cultivations
  20. Formation of recombinant proteins in Escherichia coli under control of a nitrogen regulated promoter at low and high cell densities
  21. Improved Bivalent Miniantibodies, with Identical Avidity as Whole Antibodies, Produced by High Cell Density Fermentation of Escherichia coli
  22. Improvement of recombinant gene expression in Escherichia coli for glucose-controlled continuous and fed-batch cultures
  23. Activation of fungal silent gene clusters: A new avenue to drug discovery